Effects of the SGLT2-inhibitor empagliflozin in patients with chronic syndrome of inadequate antidiuresis (SIAD) - results of a double-blind, randomized, placebo-controlled, crossover trial

Autor:	Julie Refardt, Cornelia Imber, Rianne Nobbenhuis, Odilia Sailer Clara, Aaron Haslbauer, Deborah Vogt, Manfred Berres, Bettina Winzeler, Stephanie Bridenbaugh, Christ-Crain Mirjam
Rok vydání:	2022
Zdroj:	Endocrine Abstracts.
ISSN:	1479-6848
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::886c673248e8ca72a25c3c9702dc1686 https://doi.org/10.1530/endoabs.81.p165 Zobrazit plný text záznamu